PATHWAY-2: spironolactone for resistant hypertension - Authors' reply.

Lancet

The Barts Heart Centre, William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.

Published: April 2016

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)00698-XDOI Listing

Publication Analysis

Top Keywords

pathway-2 spironolactone
4
spironolactone resistant
4
resistant hypertension
4
hypertension authors'
4
authors' reply
4
pathway-2
1
resistant
1
hypertension
1
authors'
1
reply
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!